Genenta Science S.p.A. ADR (SAEN)
NASDAQ: SAENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SAEN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $24.47M
- EPS (TTM)
- -$0.37
- Dividend yield
- None
- 52-week range
- 0.50 – 2.58
- Day range
- 0.50 – 0.5999
- Volume / Avg
- 37.64K / 85.01K
- Beta
- —
- Shares outstanding
- 48.22M
52-week range
SAEN stock today
Genenta Science S.p.A. (SAEN) closed at $0.5074 on Nov 20, down 9.39% (-$0.0526), versus the S&P 500's 3.70% decline. Trading was light, with 37.64K shares changing hands, about 44% of the average daily volume. Shares are 80.3% below their 52-week high of $2.58 and 1.5% above the 52-week low of $0.50, near the bottom of the past year's range.
Genenta Science S.p.A. has posted a net loss over the last twelve months (EPS of -$0.37), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Genenta Science S.p.A.
Company profileGenenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Pierluigi Paracchi
- Headquarters
- Milan, MI
- Employees
- 9
- IPO year
- 2021
- Website
- genenta.com
SAEN news
All SAEN newsGenenta Science S.p.A. peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PTHSPelthos Therapeutics Inc. | 6.38 | -8.73% | $25.08M | vs SAEN |
| INMBINmune Bio Inc. | 0.827 | -7.50% | $25.60M | vs SAEN |
| LONALeonaBio Inc. | 2.02 | -17.89% | $26.41M | vs SAEN |
| EXOZeXoZymes Inc. | 2.91 | -14.05% | $27.42M | vs SAEN |
| MGXMetagenomi Therapeutics Inc. | 0.565 | -7.95% | $21.36M | vs SAEN |
| CVMCel-Sci Corporation | 1.21 | -17.69% | $21.28M | vs SAEN |
| EVAXEvaxion A/S ADR | 2.25 | +10.84% | $20.75M | vs SAEN |
| KLRSKalaris Therapeutics Inc. | 1.28 | -5.19% | $30.47M | vs SAEN |
Indexes, lists and sector
Genenta Science S.p.A. stock FAQ
What is Genenta Science S.p.A.'s stock price today?
SAEN last traded at $0.5074 as of Nov 20, 4:00 PM EST, down 9.39% on the day. Prices are delayed at least 15 minutes.
Who is Genenta Science S.p.A.'s CEO?
Mr. Pierluigi Paracchi is the chief executive officer of Genenta Science S.p.A. ADR, which has about 9 employees.
What is the SAEN 52-week high?
The 52-week high for SAEN is $2.58 and the 52-week low is $0.50. The stock is currently 80.3% below its high.